These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 3103638)

  • 1. Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China.
    Zeng Y; Fan J; Zhang Q; Wang PC; Tang DJ; Zhon SC; Zheng XW; Liu DP
    AIDS Res; 1986 Dec; 2 Suppl 1():S147-9. PubMed ID: 3103638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of antibodies to AIDS-associated retrovirus in in- and out-patients in Japan.
    Ikegami N
    AIDS Res; 1986 Dec; 2 Suppl 1():S29-34. PubMed ID: 3103640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
    Abe T
    AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
    Evatt BL; Gomperts ED; McDougal JS; Ramsey RB
    N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of antibodies to HTLV-I and -III in sera from Japanese hemophiliacs.
    Abe T; Kinoshita T; Matsuda J; Ryu T; Ting RC; Aoki T; Robert-Guroff M; Miyakoshi H; Gallo RC
    Cancer Res; 1985 Sep; 45(9 Suppl):4621s-4623s. PubMed ID: 2990696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
    Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson IM; Wiechel B; Saxinger C; Gallo R
    Cancer Res; 1985 Sep; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of antibodies to LAV/HTLV III in hemophiliacs with the use of virus-inactivated clotting factors.
    Dietz B; Klose HJ; Gürtler L; Eberle J; Deinhardt F; Köhler-Vajta K; Peller P
    Thromb Haemost; 1986 Aug; 56(1):50-2. PubMed ID: 3095947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time relationship of immune changes to HTLV-III/LAV seroconversion in patients with hemophilia.
    Knutsen AP; Bouhasin JD; Lawrence DN; Roodman ST; Mueller KR; McDougal JS; Joist JH
    Ann Allergy; 1986 Nov; 57(5):376-84. PubMed ID: 2946253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and transmission of human immunodeficiency virus in Japan.
    Kurimura T; Kawatani T; Hattori N; Tsuchie H
    AIDS Res; 1986 Dec; 2 Suppl 1():S163-6. PubMed ID: 3103639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence and high titers of LAV/HTLV-III antibodies in healthy hemophiliacs in the midwestern United States.
    Goldsmith JC; Dewhurst S; Hedenskog M; Casareale D; Volsky DJ
    Am J Med; 1986 Oct; 81(4):579-83. PubMed ID: 3532787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.
    Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P
    Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS studies in Japan.
    Harada S; Yamamoto N
    Jpn J Cancer Res; 1987 May; 78(5):415-27. PubMed ID: 3112053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV and HTLV-I antibody studies: pregnant women in the 1960s, patients with AIDS, homosexuals, and individuals with tropical spastic paraparesis.
    Madden DL; Tzan NR; Roman GC; Detels R; Mundon FK; Fuccillo DA; Sever JL
    Yale J Biol Med; 1987; 60(6):569-74. PubMed ID: 2893497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LAV/HTLV-III seroconversion and disease in hemophiliacs treated in France.
    Mathez D; Leibovitch J; Sultan Y; Maisonneuve P
    N Engl J Med; 1986 Jan; 314(2):118-9. PubMed ID: 3079879
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of HTLV-III/LAV antibody in selected populations in Thailand.
    Wangroongsarb Y; Weniger BG; Wasi C; Traisupa A; Kunasol P; Rojanapithayakorn W; Fucharoen S
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):517-20. PubMed ID: 3869739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of the level of antibody to AIDS-associated virus (LAV) in sera from AIDS or AIDS related complex and Japanese hemophiliacs infected with AIDS-associated virus.
    Tsuchie H; Kawatani T; Nakayama E; Matsui T; Kurimura T; Hinuma Y
    Microbiol Immunol; 1985; 29(11):1083-7. PubMed ID: 2869397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of two ELISA kits for the demonstration of antibodies against LAV/HTLV-III].
    Heinz FX; Kunz C; Barrett N
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):196-200. PubMed ID: 3307232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV and immunosuppression.
    Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T
    Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of human immunodeficiency virus (LAV/HTLV-III)-reactive antibodies in African sera from southeastern Tanzania.
    Schüpbach J; Tanner M
    Acta Trop; 1986 Sep; 43(3):195-206. PubMed ID: 2877546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.